Editorial: Repurposing β-blockers for non-cardiovascular diseases

Front Pharmacol. 2024 Feb 9:15:1372317. doi: 10.3389/fphar.2024.1372317. eCollection 2024.

Authors

Ayaz Shahid¹, Jeffrey Wang¹, Bradley T Andresen¹, S R Wayne Chen², Ying Huang¹

Affiliations

¹ Department of Biotechnology and Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, CA, United States.
² Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.

No abstract available

Keywords: B-blockers; cancer; non-cardiovascular diseases; sepsis; β-adrenergic receptor.

Publication types

Editorial

Grants and funding